Literature DB >> 21383136

Chemistry of mycolactones, the causative toxins of Buruli ulcer.

Yoshito Kishi1.   

Abstract

Buruli ulcer is a severe and devastating skin disease caused by Mycobacterium ulcerans infection, yet it is one of the most neglected diseases. The causative toxin, referred to as mycolactone A/B, was isolated and characterized as a polyketide-derived macrolide in 1999. The current status of the mycolactone chemistry is described, highlighting the stereochemistry assignment of mycolactone A/B; total synthesis; the structure determination of mycolactone congeners from the human pathogen M. ulcerans, the frog pathogen Mycobacterium liflandii, and the fish pathogen Mycobacterium marinum; the structural diversity in the mycolactone class of natural products; the highly sensitive detection/structure-analysis of mycolactones; and some biological activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21383136      PMCID: PMC3084064          DOI: 10.1073/pnas.1015252108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Stereochemistry of the core structure of the mycolactones.

Authors:  A B Benowitz; S Fidanze; P L Small; Y Kishi
Journal:  J Am Chem Soc       Date:  2001-05-30       Impact factor: 15.419

2.  Total synthesis of the mycolactones.

Authors:  Fengbin Song; Steve Fidanze; Andrew B Benowitz; Yoshito Kishi
Journal:  Org Lett       Date:  2002-02-21       Impact factor: 6.005

3.  Complete structure of the mycolactones.

Authors:  S Fidanze; F Song; M Szlosek-Pinaud; P L Small; Y Kishi
Journal:  J Am Chem Soc       Date:  2001-10-17       Impact factor: 15.419

4.  Synthesis of the mycolactone core by ring-closing metathesis.

Authors:  Matthew D Alexander; Shaun D Fontaine; James J La Clair; Antonio G Dipasquale; Arnold L Rheingold; Michael D Burkart
Journal:  Chem Commun (Camb)       Date:  2006-09-21       Impact factor: 6.222

5.  Total Synthesis of Mycolactones A and B.

Authors:  Fengbin Song; Steve Fidanze; Andrew B Benowitz; Yoshito Kishi
Journal:  Tetrahedron       Date:  2007-06-25       Impact factor: 2.457

6.  Total synthesis and stereochemistry of mycolactone F.

Authors:  Han-Je Kim; Yoshito Kishi
Journal:  J Am Chem Soc       Date:  2008-01-19       Impact factor: 15.419

7.  Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.

Authors:  K M George; D Chatterjee; G Gunawardana; D Welty; J Hayman; R Lee; P L Small
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

8.  Synthesis and structure assignment of the minor metabolite arising from the frog pathogen Mycobacterium liflandii.

Authors:  Thomas Spangenberg; Sylvain Aubry; Yoshito Kishi
Journal:  Tetrahedron Lett       Date:  2010-03-31       Impact factor: 2.415

Review 9.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

10.  Synthesis and structure of mycolactone E isolated from frog mycobacterium.

Authors:  Sylvain Aubry; Richard E Lee; Engy A Mahrous; Pam L C Small; Dia Beachboard; Yoshito Kishi
Journal:  Org Lett       Date:  2008-12-04       Impact factor: 6.005

View more
  19 in total

Review 1.  Natural products as mediators of disease.

Authors:  Neha Garg; Tal Luzzatto-Knaan; Alexey V Melnik; Andrés Mauricio Caraballo-Rodríguez; Dimitrios J Floros; Daniel Petras; Rachel Gregor; Pieter C Dorrestein; Vanessa V Phelan
Journal:  Nat Prod Rep       Date:  2016-11-22       Impact factor: 13.423

Review 2.  HUMAN MICROBIOTA. Small molecules from the human microbiota.

Authors:  Mohamed S Donia; Michael A Fischbach
Journal:  Science       Date:  2015-07-23       Impact factor: 47.728

Review 3.  The chemistry and biology of mycolactones.

Authors:  Matthias Gehringer; Karl-Heinz Altmann
Journal:  Beilstein J Org Chem       Date:  2017-08-11       Impact factor: 2.883

Review 4.  Pharmacologic management of Mycobacterium ulcerans infection.

Authors:  Tjip S Van Der Werf; Yves T Barogui; Paul J Converse; Richard O Phillips; Ymkje Stienstra
Journal:  Expert Rev Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.108

Review 5.  Recent advances and applications of experimental technologies in marine natural product research.

Authors:  Ke Li; Yu-Wen Chung-Davidson; Ugo Bussy; Weiming Li
Journal:  Mar Drugs       Date:  2015-04-29       Impact factor: 5.118

6.  Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease.

Authors:  Paul J Converse; Yalan Xing; Ki Hyun Kim; Sandeep Tyagi; Si-Yang Li; Deepak V Almeida; Eric L Nuermberger; Jacques H Grosset; Yoshito Kishi
Journal:  PLoS Negl Trop Dis       Date:  2014-01-02

7.  Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons: Mechanisms underlying hypoalgesia in Buruli ulcer.

Authors:  U Anand; M Sinisi; M Fox; A MacQuillan; T Quick; Y Korchev; C Bountra; T McCarthy; P Anand
Journal:  Mol Pain       Date:  2016-06-20       Impact factor: 3.395

8.  Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulcerans.

Authors:  Jean-Pierre Dangy; Nicole Scherr; Philipp Gersbach; Melanie N Hug; Raphael Bieri; Claudio Bomio; Jun Li; Sylwia Huber; Karl-Heinz Altmann; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2016-06-28

9.  Structure-activity relationship studies on the macrolide exotoxin mycolactone of Mycobacterium ulcerans.

Authors:  Nicole Scherr; Philipp Gersbach; Jean-Pierre Dangy; Claudio Bomio; Jun Li; Karl-Heinz Altmann; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2013-03-28

10.  Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer.

Authors:  Yves Thierry Barogui; Sandor-Adrian Klis; Roch Christian Johnson; Richard O Phillips; Eveline van der Veer; Cleo van Diemen; Tjip S van der Werf; Ymkje Stienstra
Journal:  PLoS Negl Trop Dis       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.